Hospira (HSP)

Add to Watchlists
Create an Alert
89.96 -0.01  -0.01% NYSE Sep 1, 12:10 Delayed 2m USD
View Full Chart
HSP Price Chart
View All Events

HSP Events

Date Type Description
07/29/2015 Earnings Hospira Inc Second Quarter Earnings Results in 2015
05/06/2015 Misc Hospira Inc AGM
04/28/2015 Earnings Hospira Inc First Quarter Earnings Results in 2015
03/20/2015 Misc 2014 Annual Report
02/12/2015 Earnings Hospira Inc Fourth Quarter Earnings in 2014 Release
02/05/2015 Misc Pfizer to Acquire Hospira
11/06/2014 09:00 EDT Misc Q3 2014 Hospira Earnings Conference Call
11/06/2014 Earnings Hospira to Host Conference Call for Third-Quarter 2014 Results
View All Performance Charts

HSP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Hospira is up 67.41% over the last year vs S&P 500 Total Return down 1.46%, Mylan up 1.21%, and The Medicines Company up 61.38%.

PDF Report for HSP

Download HSP Pro Report PDF

HSP Profile

Hospira Inc is a provider of injectable drugs and infusion technologies. The Company's business segments are Specialty Injectable Pharmaceuticals, Medication Management and Other Pharmaceuticals.

HSP Excel Add-In Codes

  • Name: =YCI("HSP","name")
  • Description: =YCI("HSP","description")
  • Sector: =YCI("HSP","sector")
  • Industry: =YCI("HSP","industry")
  • Est. Current Fiscal Year End: =YCI("HSP","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.